We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
348 result(s) found, displaying 161 to 170
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PREVYMIS letermovir 480 mg/24 mL concentrated injection for infusion vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PREVYMIS letermovir 240 mg film-coated tablet blister pack.
-
Prescription medicine registrationActive ingredients: pembrolizumab.
-
Prescription medicine registrationActive ingredients: doravirine; lamivudine; tenofovir disoproxil fumarate.
-
Prescription medicine registrationActive ingredients: doravirine.
-
Designation or determinationProvisional approval
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd